ARTICLE | Company News
University of Oxford cancer, pharmacogenetics news
January 23, 2012 8:00 AM UTC
The University of Oxford spun out Oxford Cancer Biomarkers Ltd. (Oxford, U.K.) to discover cancer biomarkers and provide cancer consulting services. CRO Quintiles Transnational Corp. (Research Triangle Park, N.C.) made a £3 million ($4.6 million) investment in the newco, which represents a 27.5% stake. ...